atlasesne biomed ltd.
General Data
Reg Number
515261386
Sector
Digital Health
Established
2015
No. of Employees
15
Stage
Initial Revenues
Additional Funding
1
Description
ATLASense develops REPHAEL platform, an ICU-grade, designed to continuously follow up on multiple co-morbidities and chronically ill populations both in the hospital and at home
Technology
Once attached with simple standard ECG electrodes to the chest, the reusable PolyMonitor generates 15 signals, simultaneously every fraction of a second and streams it to our cloud server. Our AI analytic SW analyzes unique biomarkers of early warnings and enables over 40 different indications and functions – more than any other product and at the lowest cost of care.
The All-in-One, End-to-End REPHAEL platform™ enables the earliest possible detection of life-threatening conditions and trends. Physicians and caregivers configure the system to deliver just the alerts and reports they need to better care for their patients and reduce the burden of data overload.
Targeted Customers
Clinicians, Hospitals, Remote Patient Monitoring Service Providers, Telehealth service providers, Pharmaceutical companies, Workplaces.
Management personnel
Winning details
Route name
Winning year
R&D Program second/third year request for Entitled Growth Corporate
R&D Program second/third year request for Entitled Growth Corporate
2023